Expression of SV2 isoforms during rodent brain development. - Wikidata - awgldk - TriplyDB

Expression of SV2 isoforms during rodent brain development.

Expression of SV2 isoforms during rodent brain development.

http://www.wikidata.org/entity/Q34927836

about

Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond Exploring the interaction of SV2A with racetams using homology modelling, molecular dynamics and site-directed mutagenesis Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy Puzzling Out Synaptic Vesicle 2 Family Members Functions.Disinhibition-induced transitions between absence and tonic-clonic epileptic seizures A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro Crystal Structure of the Receptor-Binding Domain of Botulinum Neurotoxin Type HA, Also Known as Type FA or H.The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer's Disease.Analysis of gene expression profiles associated with glioma progression Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses.Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats.Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy.

P2860

Q28068507-95555448-DE4B-4639-A0A7-2A381606EEF9 Q28543500-B8A4DFAD-B87D-4D63-B0F6-CAEF778C0586 Q28553612-CC1F194F-0C96-40BA-A0A6-B8B00C896419 Q33710870-6D11ACCB-77D3-48CA-9108-0E761D31FCC3 Q35902032-E06839CA-582D-42EA-9F05-BE3ED51FD2BA Q37442060-203CE4EF-2975-4FAE-B6D0-3AB8B1958EC2 Q37727928-0CAFC6F6-791A-4C8E-86EF-317CDD4E94CB Q38614499-6BD07A19-2D93-4A33-962D-D3F1D7508691 Q39339952-F8197AE3-7A8F-44D4-A4F2-3A2B683307B6 Q41111171-E9DFFECD-CDBF-423F-B9EF-D7F0B641398A Q41718355-3DF17F5B-ECCA-48E1-8859-20FA602975A9 Q48099131-C4D061C5-5439-494F-9799-44DFCFD8266F Q48258054-A2C98666-F7F1-4F67-9C39-EF0A36209410 Q50045642-271AEDE2-D596-426C-AE54-AA2E57E2345A

P2860

Expression of SV2 isoforms during rodent brain development.

http://www.wikidata.org/entity/Q34927836

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Expression of SV2 isoforms during rodent brain development.

@ast

Expression of SV2 isoforms during rodent brain development.

@en

Expression of SV2 isoforms during rodent brain development.

@nl

type

label

Expression of SV2 isoforms during rodent brain development.

@ast

Expression of SV2 isoforms during rodent brain development.

@en

Expression of SV2 isoforms during rodent brain development.

@nl

prefLabel

Expression of SV2 isoforms during rodent brain development.

@ast

Expression of SV2 isoforms during rodent brain development.

@en

Expression of SV2 isoforms during rodent brain development.

@nl

P1433

Q34927836-2318C1EA-786D-4CC3-8CC7-8EB73B84BFDD

P1476

Q34927836-9E4FD1B6-AF9E-430E-B291-6C19D5C22DEE

P2093

Q34927836-136AD68D-C82D-4067-8B2D-0F8EF26D8A7D

Q34927836-1D6D0DF2-BE5F-4F3E-8A34-27D7BB210625

Q34927836-3BBA6772-A19F-402F-9C85-786B5E48D232

Q34927836-5BB8F857-1892-4B8E-AB1F-53055AD42055

Q34927836-75EACF64-0D3D-4F55-B3FD-C48139D79C99

Q34927836-83199A87-41D0-477D-978C-F0AF64E78F0F

Q34927836-9FBF119E-91CF-48CE-893C-C8166452D4DC

Q34927836-FACBD965-C042-403D-8E58-DA41EB90CCB4

P2860

Q34927836-02A8C2C7-413C-4679-867F-091152123957

Q34927836-08C360D4-F234-4584-92C5-6792F07AC03C

Q34927836-0A3E05B2-B400-49CE-9E47-CD6EDEA144D7

Q34927836-141A8086-2676-4187-949D-6A71F1773C42

Q34927836-1DB1136D-2795-4237-8F65-25CD714E4779

Q34927836-1FB5C85F-B09E-4037-B1AB-CD211A1072B3

Q34927836-1FF7E253-10A9-4BE4-AD8C-6A21E2B10692

Q34927836-27157876-DA39-4050-A06C-24E1F4FFEDE3

Q34927836-2715D5D4-DE0A-43BB-BC53-C38F5CEB8764

Q34927836-2945C026-47B4-475F-868B-ABE7FCBDB46C

P2888

Q34927836-6E94B1EB-4844-48DC-83BE-7E3D46013BFB

P304

Q34927836-03BF20FF-DAF6-4EB9-B5D9-E6225EA4413E

P31

Q34927836-8F62D491-A51A-4AB3-A3A8-508B1B81FD49

P356

Q34927836-90DECA28-38BB-4136-B367-D4B0C02DAFAC

P478

Q34927836-772D08FD-98D9-48C6-8BB5-9D04C1317D96

P577

Q34927836-E0394FAE-8E54-47A4-8437-7AB784CEEDB0

P5875

Q34927836-B611C52C-06F2-40AB-AF16-54E99D5E8FFE

P6179

Q34927836-AE62B62A-4B99-4594-83D4-DBC555A5FE91

P698

Q34927836-287DDD41-79A5-4E48-9B16-188E6BD39C47

P932

Q34927836-DB2D1B78-074D-4672-AEEF-F3E3340EE286

P356

1471-2202-14-87

P1433

BMC Neuroscience

P1476

Expression of SV2 isoforms during rodent brain development.

@en

P2093

Bernard Rogister

http://www.w3.org/2001/XMLSchema#string

Caroline Thielen

http://www.w3.org/2001/XMLSchema#string

Catherine Vandenplas

http://www.w3.org/2001/XMLSchema#string

Gustave Moonen

http://www.w3.org/2001/XMLSchema#string

Julie Crèvecœur

http://www.w3.org/2001/XMLSchema#string

Manuel Deprez

http://www.w3.org/2001/XMLSchema#string

Melissa Doupagne

http://www.w3.org/2001/XMLSchema#string

Patrik Foerch

http://www.w3.org/2001/XMLSchema#string

P2860

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

Brain contains two forms of synaptic vesicle protein 2

Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)

SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis

Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A.

Brivaracetam (UCB 34714)

Synaptic vesicle protein 2 enhances release probability at quiescent synapses

SV2A and SV2B function as redundant Ca2+ regulators in neurotransmitter release

SV2, a brain synaptic vesicle protein homologous to bacterial transporters

Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin

P2888

1471-2202-14-87

P304

87

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2202-14-87

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255787923

http://www.w3.org/2001/XMLSchema#string

P6179

1004804827

http://www.w3.org/2001/XMLSchema#string

P698

23937191

http://www.w3.org/2001/XMLSchema#string

P932

3765414

http://www.w3.org/2001/XMLSchema#string